FMC Corporation Deferred Revenue 2011-2025 | FMC

Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.

Features of the metric

Sources of future cash inflows
A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability.
Assessment of operational stability
Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages.
Risks and obligations
Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results.
Analysis of liquidity and cash flow
Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks.
Impact on company valuation
In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).

Annual Deferred Revenue FMC Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
454 M	482 M	680 M	631 M	453 M	602 M	562 M	446 M	240 M	250 M	190 M	179 M	140 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
680 M	140 M	408 M

Quarterly Deferred Revenue FMC Corporation

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	1.8 M	400 K	800 K	88.7 M	1.7 M	3.4 M	14 M	680 M	3.3 M	-	40 M	631 M	3.2 M	2.8 M	12 M	347 M	347 M	347 M	347 M	493 M	493 M	493 M	493 M	458 M	458 M	458 M	458 M	381 M	-	381 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
680 M	400 K	266 M

Deferred Revenue of other stocks in the Agricultural inputs industry

Issuer	Deferred Revenue	Price	% 24h	Market Cap	Country
Акрон AKRN	1.94 B	-	-	-	Russia
Bioceres Crop Solutions Corp. BIOX	2.87 M	$ 1.58	0.32 %	$ 435 M	Argentina
ФосАгро PHOR	13 B	-	-	-	Russia
China Green Agriculture CGA	7.34 M	-	0.51 %	$ 27.6 M	China
CF Industries Holdings CF	149 M	$ 78.47	-0.93 %	$ 14.2 B	USA
ICL Group Ltd ICL	17 M	$ 4.96	-2.27 %	$ 7.83 B	Israel
Corteva CTVA	3.29 B	$ 65.27	-1.21 %	$ 45.3 B	USA
American Vanguard Corporation AVD	6.83 M	$ 4.05	-6.25 %	$ 114 M	USA
Intrepid Potash IPI	800 K	$ 26.81	-1.14 %	$ 345 M	USA
Marrone Bio Innovations MBII	360 K	-	-5.9 %	$ 180 M	USA
Nutrien Ltd. NTR	1.8 B	$ 60.84	-3.26 %	$ 34.8 B	Canada
The Mosaic Company MOS	271 M	$ 25.53	-2.63 %	$ 8.16 B	USA
Yield10 Bioscience YTEN	277 K	-	15.32 %	$ 46.6 M	USA
Arcadia Biosciences RKDA	8 K	$ 3.73	2.47 %	$ 4.61 M	USA
Origin Agritech Limited SEED	7 M	$ 1.36	-5.76 %	$ 7.64 M	China
CVR Partners, LP UAN	50.8 M	$ 95.6	0.25 %	$ 1.01 B	USA